Literature DB >> 7203605

Plasma norepinephrine in essential hypertension. A study of the studies.

D S Goldstein.   

Abstract

Of 32 studies comparing plasma norepinephrine concentrations in hypertensive and normotensive groups, 28 (88%) reported higher levels in the hypertensive group. However, only 13 (41%) of the studies reported statistically significant hypertensive-normotensive differences in norepinephrine, leading the present attempt to identify factors differentiating "positive" studies (those reporting significant hypertensive-normotensive differences) from "negative" studies (those reporting nonsignificant differences). Hypertensive norepinephrine levels were similar in positive and negative studies (281 vs 288 pg/ml), but normotensive levels were lower in the positive studies (177 vs 269 pg/ml). When compared with the fluorimetric technique, the radioenzymatic type of assay was associated both with a lower frequency of positive results (25% vs 100%) and greater intrastudy standard deviations (152 vs 72 pg/ml). Hypertensive-normotensive differences varied inversely with age (r = -0.37). Resolution of the persisting controversy about norepinephrine levels in essential hypertension will require more attention to the causes of variability associated with the assay technique, to the sources, characteristics, and treatment of the normotensive controls, and to the age of the patient population.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7203605     DOI: 10.1161/01.hyp.3.1.48

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

1.  [Adrenergic receptors and hypertension in pregnancy].

Authors:  M Middeke
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.

Authors:  A S Hollister; J Onrot; S Lonce; J H Nadeau; D Robertson
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

3.  G-protein-coupled receptor kinase activity is increased in hypertension.

Authors:  R Gros; J L Benovic; C M Tan; R D Feldman
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  Noradrenaline: a circulating inhibitor of sodium transport.

Authors:  A Riozzi; A M Heagerty; R F Bing; H Thurston; J D Swales
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

Review 5.  Neural and nonneural mechanisms for sex differences in elderly hypertension: can exercise training help?

Authors:  Qi Fu; Wanpen Vongpatanasin; Benjamin D Levine
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

Review 6.  Blood platelets in human essential hypertension.

Authors:  F De Clerck
Journal:  Agents Actions       Date:  1986-08

7.  Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.

Authors:  Mirnela Byku; Heather Macarthur; Thomas C Westfall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

8.  Adrenaline increases glucose transport via a Rap1-p38MAPK pathway in rat vascular smooth muscle cells.

Authors:  Y Kanda; Y Watanabe
Journal:  Br J Pharmacol       Date:  2007-04-23       Impact factor: 8.739

9.  Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension.

Authors:  D S Goldstein; D Horwitz; H R Keiser; R J Polinsky; I J Kopin
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  Pioneer Award Address: ignorance isn't biased: comments on receiving the Pioneer Award.

Authors:  David S Goldstein
Journal:  Cleve Clin J Med       Date:  2009-04       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.